cms_HI: 73

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

Data source: Big Local News · About: big-local-datasette

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
73 HALE MAKUA - KAHULUI 125007 472 KAULANA STREET KAHULUI HI 96732 2019-11-26 756 D 0 1 6SOG11 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and record review, the facility failed to ensure the attending physician responded to the pharmacist's recommendation regarding the use of an antipsychotic medication ([MEDICATION NAME]) for Resident (R)137. As a result of this deficiency, R137 could potentially experience adverse outcomes and may not be receiving the lowest possible dose with the most benefit. Findings include: A record review found a progress note, 04/27/19 at 09:39 AM by Pharm1 documenting a Drug Regimen Review (DRR) was completed. Pharm1 documented, R137 has been receiving an antipsychotic [MEDICATION NAME] 0.25 mg QAM (every morning) and 0.5 mg QPM (every night) since 10/21/18. Pharm1 requested the attending physician complete an evaluation of the current dose and to consider a gradual taper of the dose to ensure (R137) is receiving the lowest possible effective/optimal dose. There was no documentation of the pharmacist's report to the physician regarding use of [MEDICATION NAME] or a response from the physician. A subsequent review by the pharmacist on 05/30/19 at 09:31 PM, notes the attending physician failed to respond to a previous request for an evaluation/gradual taper of dose for [MEDICATION NAME]. At this time, Pharm1 planned to resend last months note (dated 04/27/19). On 11/22/19 at 08:51 AM, the Assistant Director of Nurses (ADON) was unable to find the 04/27/19 documentation of the correspondence from the pharmacist to the attending physician. The ADON provided documentation which was dated 05/31/19 in which the attending physician responded to the pharmacist. The date of the response is illegible (possibly (MONTH) 2019). 2020-09-01